You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sulindac

Showing 1 - 25 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Los Angeles, Stony Brook (Sulindac Pill, Placebo)

Recruiting
  • Breast Cancer
  • Sulindac Pill
  • Placebo
  • Los Angeles, California
  • +1 more
Jan 18, 2023

Fragile X Syndrome Trial in Australia, United States (Sulindac (HLX-0201), dose strength 1, Sulindac (HLX-0201), dose strength

Withdrawn
  • Fragile X Syndrome
  • Sulindac (HLX-0201), dose strength 1
  • +3 more
  • Aurora, Colorado
  • +9 more
Dec 7, 2022

Familial Adenomatous Polyposis Trial in Worldwide (Eflornithine, Eflornithine Placebo, Sulindac 150 MG)

Completed
Has Results
  • Familial Adenomatous Polyposis
  • La Jolla, California
  • +16 more
May 12, 2021

IPMN, IPMN, Pancreatic Trial in United States (Sulindac 400 MG, Placebo)

Recruiting
  • IPMN
  • IPMN, Pancreatic
  • Sulindac 400 MG
  • Placebo
  • Baltimore, Maryland
  • +3 more
Feb 16, 2022

Leukoplakia, Oral, Benign Tumors Trial in New York, Cochin, Trivandrum (sulindac, Placebo)

Completed
Has Results
  • Leukoplakia, Oral
  • Benign Neoplasms
  • sulindac
  • Placebo
  • New York, New York
  • +2 more
Oct 23, 2020

Desmoid Tumor Trial in Monrovia (tamoxifen citrate, sulindac, laboratory biomarker analysis)

Completed
Has Results
  • Desmoid Tumor
  • tamoxifen citrate
  • +2 more
  • Monrovia, California
    Children's Oncology Group
Feb 7, 2020

Colorectal Tumors Trial in United States (Eflornithine & sulindac , eflornithine & sulindac , Eflornithine & sulindac)

Recruiting
  • Colorectal Neoplasms
  • Eflornithine placebo & sulindac placebo
  • +3 more
  • Birmingham, Alabama
  • +985 more
Aug 23, 2022

Inflammation, Cancer, Pain Trial in Tucson, Stony Brook (Sulindac)

Unknown status
  • Inflammation
  • +3 more
  • Sulindac
  • Tucson, Arizona
  • +1 more
Nov 28, 2018

Cerebral Cavernous Malformation Trial in Italy (Propranolol)

Completed
  • Cerebral Cavernous Malformation
  • San Giovanni Rotondo, FG, Italy
  • +5 more
Feb 24, 2022

Precancerous Condition Trial in Tucson, Stanford (sulindac, , laboratory biomarker analysis)

Completed
Has Results
  • Precancerous Condition
  • sulindac
  • +2 more
  • Tucson, Arizona
  • +1 more
Nov 30, 2017

Familial Adenomatous Polyposis (FAP) Trial in Milano (Anti-inflammatory Diet)

Completed
  • Familial Adenomatous Polyposis (FAP)
  • Anti-inflammatory Diet
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Sep 10, 2020

Familial Adenomatous Polyposis Trial in San Juan (Calcumin (Curcumin), Risk Factor Questionnaire, Blood samples)

Completed
Has Results
  • Familial Adenomatous Polyposis
  • Calcumin (Curcumin)
  • +4 more
  • San Juan, Puerto Rico
    University of Puerto Rico Comprehensive Cancer Center
Nov 18, 2020

Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Boston (Bevacizumab, erlotinib, Sulindac)

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Boston, Massachusetts
  • +1 more
Mar 15, 2017

Acute Myeloid Leukemia Trial in Boston (Cytarabine, Sulindac)

Withdrawn
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
    Massachusetts General Hospital
Feb 15, 2017

Colon Cancer, Precancerous Condition, Rectal Cancer Trial in Rochester (oligofructose-enriched inulin, sulindac, )

Completed
Has Results
  • Colon Cancer
  • +2 more
  • oligofructose-enriched inulin
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 28, 2016

Meningitis Streptococcal, Hiv, Meningitis Trial in Ho Chi Minh City (Tamoxifen, Amphotericin B, Fluconazole)

Completed
  • Meningitis Streptococcal
  • +3 more
  • Ho Chi Minh City, Vietnam
  • +2 more
Nov 28, 2019

Lung Cancer Trial in Worldwide (carboplatin, exisulind, gemcitabine HCl)

Completed
  • Lung Cancer
  • Birmingham, Alabama
  • +78 more
Dec 30, 2018

Adenomatous Polyposis Coli Trial in Salt Lake City (Erlotinib, Sulindac, Placebo A)

Completed
Has Results
  • Adenomatous Polyposis Coli
  • Salt Lake City, Utah
    Huntsman Cancer Institute
May 10, 2016

Prostate Cancer Trial in Seattle (Exisulind, luteinizing hormone-releasing hormone (LHRH) agonist, Antiandrogen)

Completed
Has Results
  • Prostate Cancer
  • Seattle, Washington
    Seattle Cancer Care Alliance
Aug 3, 2018

Head and Neck Squamous Cell Carcinoma Trial in Pittsburgh (Erlotinib, Erlotinib plus sulindac, Placebo)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Jan 28, 2016

Colorectal Cancer, Liver Metastasis, Colorectal Adenocarcinoma Trial run by the NCI (Sulindac, Placebo, Validate assays and

Terminated
Has Results
  • Colorectal Cancer
  • +2 more
  • Sulindac
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 22, 2015

Cancer Genetics Hereditary Cancer Panel Testing

Completed
  • Hereditary Breast and Ovarian Cancer
  • Questionnaires
  • Blood Draw and Baseline Questionnaire
  • Los Angeles, California
  • +1 more
Apr 8, 2017

Solid Tumor Trial in Rochester (sulindac, pharmacological study)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • sulindac
  • pharmacological study
  • Rochester, Minnesota
    Mayo Clinic Cancer Center
Apr 27, 2015

Familial Adenomatous Polyposis Trial (Eflornithine plus Sulindac, Eflornithine plus Placebo, Sulindac plus Placebo)

Withdrawn
  • Familial Adenomatous Polyposis
  • Eflornithine plus Sulindac
  • +2 more
  • (no location specified)
Apr 23, 2015

Lung Cancer Trial in Canada, Puerto Rico, United States (carboplatin, etoposide, exisulind)

Completed
  • Lung Cancer
  • Anniston, Alabama
  • +82 more
Dec 5, 2016